2019 Q3/Global Life Sciences
Rank | Chg | Organisation name | Overall |
|
---|---|---|---|---|
|
||||
1 | +1 |
Cytogen
|
7.1 | |
|
||||
2 | +3 |
Dainippon Sumitomo
|
6.6 | |
|
||||
3 | +12 |
Zambon
|
5.9 | |
|
||||
4 | -3 |
Pfizer UK
|
5.8 | |
|
||||
5 | +1 |
Yakult UK
|
5.7 | |
|
||||
6 | +6 |
Genus
|
5.7 | |
|
||||
7 | +0 |
Galenica AG
|
5.6 | |
|
||||
8 | +14 |
Takeda UK
|
5.6 | |
|
||||
9 | -6 |
Ligand Pharmaceuticals
|
5.6 | |
|
||||
10 | +0 |
Hetero
|
5.4 | |
|
||||
11 | +154 |
Purdue Pharma
|
5.3 | |
|
||||
12 | +11 |
EISAI UK
|
5.3 | |
|
||||
13 | -9 |
Shionogi
|
5.2 | |
|
||||
14 | +2 |
Medivir Group
|
5.2 | |
|
||||
15 | +2 |
Debiopharm
|
5.1 | |
|
||||
16 | -7 |
Alcon
|
5.1 | |
|
||||
17 | +7 |
Apotex
|
5.1 | |
|
||||
18 | +0 |
Abbott Uk
|
5.1 | |
|
||||
19 | +16 |
Zandu
|
4.9 | |
|
||||
20 | +39 |
Mochida
|
4.9 | |
|
||||
21 | +26 |
Takeda
|
4.9 | |
|
||||
22 | +41 |
Perrigo
|
4.9 | |
|
||||
23 | +42 |
Elan
|
4.9 | |
|
||||
24 | +5 |
Laboratoires Thea UK
|
4.8 | |
|
||||
25 | -11 |
Kyorin Holdings
|
4.8 | |
|
||||
26 | +0 |
Recordati
|
4.8 | |
|
||||
27 | +0 |
ALK-Abello
|
4.8 | |
|
||||
28 | +50 |
Nippon Chemiphar
|
4.8 | |
|
||||
29 | +1 |
Lilly
|
4.7 | |
|
||||
30 | +9 |
Toray Industries
|
4.7 | |
|
||||
31 | +1 |
Bavarian Nordic
|
4.7 | |
|
||||
32 | +1 |
Actelion
|
4.7 | |
|
||||
33 | -20 |
QLT
|
4.6 | |
|
||||
34 | +0 |
ARIAD Pharmaceuticals
|
4.6 | |
|
||||
35 | +39 |
Biotest
|
4.6 | |
|
||||
36 | +2 |
Nippon Kayaku
|
4.5 | |
|
||||
37 | +9 |
Wockhardt UK
|
4.5 | |
|
||||
38 | +6 |
ProMetric Life Sciences
|
4.5 | |
|
||||
39 | +6 |
Bial Portela
|
4.5 | |
|
||||
40 | +14 |
Avanir Pharmaceuticals
|
4.4 | |
|
||||
41 | +19 |
Zydus Cadila
|
4.4 | |
|
||||
42 | +11 |
Asahi Kasei
|
4.4 | |
|
||||
43 | +0 |
Teijin Europe
|
4.4 | |
|
||||
44 | -3 |
Esteve
|
4.4 | |
|
||||
45 | -24 |
Bosnalijek
|
4.4 | |
|
||||
46 | +3 |
Leo Pharma UK
|
4.4 | |
|
||||
47 | -39 |
Baxter Healthcare UK
|
4.4 | |
|
||||
48 | -8 |
Acorda Therapeutics
|
4.3 | |
|
||||
49 | +1 |
Otsuka Pharmaceuticals Europe
|
4.3 | |
|
||||
50 | +16 |
China Pharmaceutical Group
|
4.3 | |
|
Changes in rank are compared to 2019 Q2/Global Life Sciences. Since then, 1 site entered the survey and 86 sites could not be included in the rankings (1 more since last time). Build your own. Report statistics.
Priorities Summary
The priorities for this organization are not currently available to view.
Contact Us